Clinical Trial - Trial jRCT2041220154
Access comprehensive clinical trial information for jRCT2041220154 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruiting. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2041220154
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2041220154
Untitled Trial
Randomized phase II study comparing efficacy and safety of alpha fetoprotein derived peptides to placebo for the patients with advanced hepatocellular carcinoma after transarterial chemoembolization for hepatocellular carcinoma
Study Focus
Interventional
Sponsor & Location
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Malignant neoplasm: Hepatoblastoma
Malignant neoplasm: Liver cell carcinoma
Malignant neoplasm: Other specified carcinomas of liver
Malignant neoplasm: Liver, unspecified
Malignant neoplasm: Hepatic flexure
Data Source
Japan Registry Clinical Trial
jRCT2041220154
Non-Device Trial